Delivery Order SPE2DB22D2007-SPE2DB24FJ0QK
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the Department of Defense with Entresto 49 mg-51 mg tablets. The contract, valued at $15,060.89, has a period of performance through March 19, 2024. Amerisourcebergen is the prime contractor and there is no set-aside designation for this award. In addition to this specific delivery order,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $41,847.64 contract is for the supply of Entresto 24 mg-26 mg tablets in 180-count bottles, with a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENTRESTO 24 MG-26 MG tablets in 180 count bottles. The contract has a ceiling value of $15,425.32 and a performance period through April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a $9,274.86 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 180 tablets of the drug ENTRESTO (97 mg-103 mg). This delivery order contract falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENTRESTO 24 MG-26 MG tablets in 180 count packages. The award has a completion date of February 12, 2024 and a potential value of $1,282.51. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Entresto 24 mg-26 mg tablets in quantities of 180 per bottle. The contract has a completion date of July 16, 2025 and a ceiling value of $14,442.32. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ENTRESTO 97 MG-103 MG TABLET 180S. The contract has a ceiling value of $2,384.62 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $11,393.37 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count packaging) on November 10, 2025, with an ultimate completion date of November 12, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $61,266.45 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 180S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0QKDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) to provide Entresto 49 mg-51 mg tablets in 60-count packages. The $14,114.35 award has an ultimate completion date of March 18, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 3/15/24 |